Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain

Item
http://www.wikidata.org/entity/Q34118976
Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalPrevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach.Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics folloMastering tricyclic ring systems for desirable functional cannabinoid activity.In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
P2860

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain

Item
http://www.wikidata.org/entity/Q34118976
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacological characterizati ...... treatment of neuropathic pain
@ast
Pharmacological characterizati ...... treatment of neuropathic pain
@en
Pharmacological characterizati ...... treatment of neuropathic pain
@nl
type
label
Pharmacological characterizati ...... treatment of neuropathic pain
@ast
Pharmacological characterizati ...... treatment of neuropathic pain
@en
Pharmacological characterizati ...... treatment of neuropathic pain
@nl
prefLabel
Pharmacological characterizati ...... treatment of neuropathic pain
@ast
Pharmacological characterizati ...... treatment of neuropathic pain
@en
Pharmacological characterizati ...... treatment of neuropathic pain
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Pharmacological characterizati ...... treatment of neuropathic pain
@en
P2093
P2860
P304
P31
P356
10.1213/ANE.0B013E3181E0CDAF
P407
P433
P478
P577
P698
P921
P932